Natco Pharma Analyst Rating
based on 11 analysts
36.36%
Buy
27.27%
Hold
36.36%
Sell
Based on 11 analysts offering long term price targets for Natco Pharma. An average target of ₹1337.27
Source: S&P Global Market Intelligence
Natco Pharma Share analysis
Natco Pharma price forecast by 11 analysts
Upside of7.89%
High
₹1675
Target
₹1337.27
Low
₹690
Natco Pharma target price ₹1337.27, a slight upside of 7.89% compared to current price of ₹1239.5. According to 11 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Natco Pharma revenue growth forecast
Expected growth rate Q1, FY2027:
Forecast
Actual
Including amortisation and stock based compensations
Natco Pharma EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Natco Pharma Performance
Day's Low
Day's High
₹1,229.1Day's Price Range₹1,245.652 Week's Low
52 Week's High
₹80552-Week Price Range₹1,639
| Returns % | |
| 1 Month Return | -14.27 % |
| 3 Month Return | -11.38 % |
| 1 Year Return | + 49.77 % |
| Market Stats | |
| Previous Close | ₹1,245.60 |
| Open | ₹1,245.60 |
| Volume | 2.36L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹22,309.93Cr |
Natco Pharma Key Statistics
| P/E Ratio | 11.42 |
| PEG Ratio | 0.25 |
| Market Cap | ₹22,309.93 Cr |
| P/B Ratio | 3.05 |
| EPS | 77.56 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 25.38 |
Natco Pharma Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹22,309.93 Cr | 18.73% | 0.54 | ₹1,388 Cr | ₹3,998 Cr | |
| BUY | ₹12,534.65 Cr | -3.67% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
| BUY | ₹67,752.08 Cr | 28.8% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
| HOLD | ₹99,431.01 Cr | 54.52% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
| BUY | ₹58,008.46 Cr | 24.18% | 0.53 | NA | NA |
About Natco Pharma
Share Price: ₹1239.50 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹22,309.93Cr as of today
Revenue: ₹1,371.10Cr as on September 2024 (Q3 24)
Net Profit: ₹676.50Cr as on September 2024 (Q3 24)
Listing date: 27 Dec, 1995
Chairperson Name: G S Murthy
| Organisation | Natco Pharma |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Natco Pharma Ltd
Tata Mutual Fund Acquires Stake in Natco Pharma - 12 Jan, 2025
Tata Mutual Fund has acquired a 1.28% stake in Natco Pharma Limited, purchasing 22.96 lakh equity shares. Despite this investment, Natco's shares closed down 4.15% at Rs. 1,235.50.Natco Pharma's Diverse Customer Base Highlighted - 20 Dec, 2024
As of June 30, 2024, Natco Pharma serves 443 customers across various sectors, including 30 of the 80 pharmaceutical and chemical companies in the NSE 500 index.
Insights on Natco Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 795.6 Cr → 1.43K Cr (in ₹), with an average increase of 17.1% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 17.51% to 17.94% in Dec 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 212.7 Cr → 677.3 Cr (in ₹), with an average increase of 29.5% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 26.12% to 26.87% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 71.8%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 3.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.62% of holdings in Dec 2024 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 2.37% to 1.92% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, NATCOPHARM stock has moved down by -14.8%
Natco Pharma Financials
Index Inclusions
Natco Pharma Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.62% | 0.00 | |
| Foreign Institutions | 17.94% | 2.44 | |
| Mutual Funds | 1.92% | ||
| Retail Investors | 26.87% | 2.88 | |
| Others | 3.66% |
Natco Pharma Key Indicators
Natco Pharma Valuation
Natco Pharma in the last 5 years
Lowest (11.16x)
January 13, 2025
Today (11.42x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (90.32x)
April 6, 2022
Natco Pharma Earnings and Dividends
Natco Pharma Ltd Earnings Results
Natco Pharma Ltd’s net profit jumped 83.55% since last year same period to ₹677.30Cr in the Q2 2024-2025. On a quarterly growth basis, Natco Pharma Ltd has generated 1.32% jump in its net profits since last 3-months.
Read More about Earnings ResultsNatco Pharma Ltd Dividends November,2024
In the quarter ending September 2024, Natco Pharma Ltd has declared dividend of ₹1.50 - translating a dividend yield of 0.56%.
Read More about Dividends
Natco Pharma Technicals Summary
Bearish
Neutral
Bullish
Natco Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Natco Pharma Ltd
Natco Pharma Ltd share price today stands at ₹1239.5, Open. ₹1245.6 ; Previous Close. ₹1245.6 ; High. ₹1245.6 ; Low. ₹1229.1 ; 52 Week High. ₹1639 ; 52 Week Low: ₹805.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Natco Pharma Ltd shares.
Natco Pharma Ltd is listed on NSE
Natco Pharma Ltd is listed on BSE
- Today’s highest price of Natco Pharma Ltd is ₹1245.6.
- Today’s lowest price of Natco Pharma Ltd is ₹1229.1.
PE Ratio of Natco Pharma Ltd is 11.42
PE ratio = Natco Pharma Ltd Market price per share / Natco Pharma Ltd Earnings per share
Today’s traded volume of Natco Pharma Ltd(NATCOPHARM) is 2.36L.
Today’s market capitalisation of Natco Pharma Ltd(NATCOPHARM) is ₹22309.93Cr.
| Natco Pharma Ltd(NATCOPHARM | Price |
|---|---|
52 Week High | ₹1639 |
52 Week Low | ₹805 |
Natco Pharma Ltd(NATCOPHARM) share price is ₹1239.5. It is down -24.37% from its 52 Week High price of ₹1639
Natco Pharma Ltd(NATCOPHARM) share price is ₹1239.5. It is up 53.98% from its 52 Week Low price of ₹805
| Natco Pharma Ltd(NATCOPHARM | Returns |
|---|---|
1 Day Returns | -6.1% |
1 Month Returns | -14.27% |
3 Month Returns | -11.38% |
1 Year Returns | 49.77% |